Immatics N.V. 4

Carter Paul Rutherford received a stock option award for 48,000 Immatics N.V. ordinary shares at a $9.09 exercise price.

On June 16, 2026, reporting person Carter Paul Rutherford received a grant of stock options to purchase 48,000 ordinary shares of Immatics N.V. at an exercise price of $9.09 per share, with the options vesting 100% on the first anniversary of the grant date and expiring on June 15, 2036. The grant appears to be a routine equity compensation award, resulting in derivative ownership of 48,000 shares underlying the options; the dollar value of the grant, based on the exercise price, is approximately $436,320. The filing does not provide additional common share holdings or a market price snapshot, so the value of his total post‑transaction holdings is estimated using the option exercise price as a proxy.

Filing Facts

CIK

1809196

Ticker

IMTX

Form

4

Source Type

fda

Accession

0000950103-26-009242

Alert Tier

5